Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 985 | 965 | 860 | 894 | 1165 | 1565 |
Fund Return | -1.53% | -3.48% | -14% | -3.68% | 3.1% | 4.58% |
Place in category | 123 | 118 | 109 | 80 | 51 | 8 |
% in Category | 60 | 59 | 61 | 59 | 81 | 56 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
China Southern AnTai mix | 4.2B | 1.74 | 1.20 | - | ||
Southern China Good Returns Fund A | 3.82B | 7.92 | -10.19 | 9.72 | ||
China Southern Privileged Opportuni | 3.54B | 5.44 | -16.16 | 11.85 | ||
China Southern Transform Growth All | 3.34B | 1.05 | -3.01 | - | ||
China Southern Healthcare Balanced | 2.84B | -7.29 | -18.43 | 9.48 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fullgoal China Securities 500 Index | 7.2B | -0.33 | -1.91 | 9.20 | ||
CCB Principal CSI 500 Index Fund | 4.9B | -0.98 | -3.58 | 9.21 | ||
CMF Quantity Select Eq | 3.41B | -3.96 | 8.85 | - | ||
China Univ Gr Factor Quant Strat Eq | 3.24B | -2.66 | -1.44 | - | ||
TianHong CSI 500 Index Fd A | 2.3B | -1.49 | -3.37 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Southern CSI 500 Index | CNE099900464 | 93.31 | 5.30 | +1.28% | |
TREASURY COUPON BOND 2022 14 | - | 1.92 | - | - | |
TREASURY COUPON BOND 2023 10 | - | 1.30 | - | - | |
TREASURY COUPON BOND 2022 5 | - | 1.07 | - | - | |
TREASURY COUPON BOND 2020 9 | - | 0.98 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review